Advancements in Lipid Nanotechnology for the Treatment of Triple-Negative Breast Cancer: Mechanistic Insights and Future Prospects
作者
Issac V Cherian,Harpreet Kaur,Kamre Aalam,Janvi,Sourabh Kosey,Akash Vikal
出处
期刊:Nano LIFE [World Scientific] 日期:2026-07-18
标识
DOI:10.1142/s1793984426300165
摘要
The high resistance to therapy, molecular heterogeneity, early metastasis and quick drug resistance make triple-negative breast cancer (TNBC) difficult and even impossible to treat. Conventional chemotherapy is highly toxic, not specifically targeting the tumor and has limited efficacy, so more sophisticated delivery mechanisms are required. To overcome these shortcomings, lipid nanotechnology is provided as a controlled, targeted and multifunctional drug delivery system. This review outlines the recent developments of lipid nanoparticles for TNBC, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, lipid–polymer hybrids, ionizable lipid nanoparticles and biomimetic vesicles. These systems enable improved tumor targeting and delivery of chemotherapeutics, gene-editing agents and combination therapeutics. Rational design, targeting strategies, modulation of the tumor microenvironment, targeting cancer stem cells and breaking multidrug resistance are highlighted. Pharmacokinetic, safety, manufacturing, regulatory and translational issues are discussed, along with preclinical and emerging clinical evidence. Lastly, future directions are suggested to help develop modular, precise and clinically scalable lipid nanoparticle systems for effective management of TNBC.